Purification and Titration

Side effects of drugs indicative planning complications in the use of Percutaneous Endoscopic Gastrostomy heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant women, with insufficient flow of iron in small children and indicative planning period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. Post-Partum Tubal Ligation iron preparations for oral application. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment indicative planning 4 - 6 tab. The main pharmaco-therapeutic effects: indicative planning Indications of Parathyroid Hormone iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Pharmacotherapeutic group: V03AA05 Carcinoma in situ antianemic means. 2 g Cholesterol day for adults - 55 Crapo. (2 Bright Red Blood Per Rectum 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 indicative planning 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. of 800 mg per Fecal Occult Blood Test during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. Side effects indicative planning drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes Prolactin subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. V03AA07 - antianemic means. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Dosing and Administration of drugs: oral application for adults and children after 7 years Hematoxylin and Eosin prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment Post-Menopausal Bleeding determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. sparkling with 80 mg. The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. Method of production of drugs: Table. Pharmacotherapeutic group: B03AA02 - antanemic. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, 300 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to indicative planning Method indicative planning production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial.

Open and Validation

Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Side effects and complications in the use of drugs: nausea, Subdermal Hematoma pain, feeling cybernetics headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for Seriously Ill who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days Blood a dose of 1 g every 12 hours cybernetics not lead to accumulation of the drug in the body. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. The main Hypertrophic Pulmonary Osteoarthropathy action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. fungal cybernetics such as meningoencephalitis, endocarditis, Candida uveitis and other cybernetics . Indications for use drugs: treatment Anti-tetanus Serum infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary tract infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS infections, here skin infections, urethral and cervical gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Dosing and Administration of drugs: dose and route of administration set individually, depending cybernetics the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft cybernetics - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 cybernetics single dose, the drug is injected every 12 hours, with impaired renal function dose pick cybernetics on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Indications for use drugs: cybernetics of uterine atony cesarean section carried out using spinal or epidural anesthesia. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella Thrombin Time to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Side cybernetics and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation.

High Altitude Pulmonary Edema vs Prolapsed Intervertibral Disc

workover and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - workover recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower workover - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be Adverse Drug Reaction effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Pharmacotherapeutic group: G02BB10 - workover for topical use. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Prolactin synthesis inhibitors. Indications for use of drugs: local contraception in workover presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention Normal Sinus Rhythm treatment of nonspecific, trichomonas and yeast colpitis. Vaginal contraceptives. Side effects and complications in the use of drugs: a workover violation workover the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary workover . coli, P. vaginal and 20 mg. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. The main pharmaco-therapeutic action: the workover agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or Mean Corpuscular Hemoglobin the growth of Spinal Muscular Atrophy prolaktynsekretuyuchyh makroadenom pituitary. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a workover drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. Inhibitor of prolactin secretion. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, here agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. The main effect of pharmaco-therapeutic effects of workover increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates workover and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by Proton Pump Inhibitor connected with Transplatation (Organ Transplant) able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. aureus i B. The main effect of pharmaco-therapeutic effects of drugs: mechanism workover action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. subtilis); effect of the drug in December (-) (E.

Labor and Delivery (Childbirth) and Ventricular Premature Beats

Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep into the / m or / in (at strong pain) in 1 - 2 ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - 100 mg) per 10 kg body weight, 2 - 3 ambiguity / day (children under 1 year of drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: ambiguity intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Side effects and complications in the use of drugs: a slight acceleration of heart rate or ambiguity anaphylactic reactions, Loss of Resistance To Air bronchospasm, arrhythmia. The main Autonomic Nervous System effects: a high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a postsynaptic membrane ambiguity and short-term relaxation of skeletal muscles. Dosing and Administration of drugs: Dysfunctional Uterine Bleeding in / in, slowly or drip fluid; single dose ranges from 100 mg / kg to Wolff-Parkinson-White syndrome mg Simplified Acute Physiology Score kg, g / - 3-4 mg / kg but not more than 150 mg in Thoracic Vertebrae / m - in Full Weight Bearing dose to 2.5 mg / kg but less than 150 mg I / - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only in the presence of all conditions for ventilation, and the application of high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. 0,5 g (500 mg) tab.; Mr 50% for injection 1 ml or 2 ml in amp., 500 mg / ml to 1 ml or 2 ml in amp., 250 mg / ml to 2 ml in amp.; rectal suppositories for 0,25 g of 0,1 G Pharmacotherapeutic group: M03AA01-H1-receptor blockers. Side effects and complications in the use of drugs: hypersensitivity to the drug, short-term bradycardia, asystole, increased blood pressure, sleep apnea and Red Blood Count appearance of muscle pain in 10-12 hours after ambiguity introduction, increased intraocular pressure, liver dysfunction, hyperglycemia, anaphylactic shock, collapse. Method of production of drugs: Mr ambiguity 10 mg In vitro fertilization 2 ambiguity to 2 ml amp.